MAPT and Alzheimer disease: Furthermore, spatial memory deficits and cognitive decline in AD could be ameliorated by FGF-2 through a simultaneous decrease in amyloid-β (Aβ) and microtubule-associated protein tau while increasing the number of resting ASTs in the hippocampal dentate gyrus (Katsouri et al., 2015).